Future Bundled Payment Models Need To Engage Physician Group Practices
Looking Forward, LDI Fellows Offer Their Perspectives and Expertise
In Their Own Words
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.
Looking Forward, LDI Fellows Offer Their Perspectives and Expertise
Fewer Than 30% of Patients Used Telehealth Even During the Pandemic
Cited for Their Work’s Significant Impact on Nursing and Patient Care
Data From 46 States Suggests No Wage Gains Among Lower-Wage Health Care Workers
Plans Often Disagree on Which Services to Review, New Study Shows
A Look at How CHCs are Funded and Reimbursed and How They Fit Into the Landscape of Value-Based Payment